Integrated antimicrobial and low fouling materials
Cationic polymers hydrolyzable to zwitterionic polymers, monomers for making the cationic polymers, surfaces that include the polymers, and methods for making and using the cationic polymers and surfaces. The cationic polymers include counterions and/or hydrolyzable groups that release active agents.
1. A polymer, comprising:
(a) polymer backbone;
(b) a plurality of cationic centers, each cationic center covalently coupled to the polymer backbone by a first linker;
(c) a counter ion associated with each cationic center; and
(d) a hydrolyzable group covalently coupled to each cationic center through a second linker, wherein the hydrolyzable group is hydrolyzable to an anionic center to provide a zwitterionic polymer having the anionic center covalently coupled to the cationic center through the second linker,
wherein at least a portion of the counter ions are antimicrobial agents, antibacterial agents, or antifungal agents, and/or
wherein at least a portion of the hydrolyzable groups release an antimicrobial agent, an antibacterial agent, or an antifungal agent.
2. The polymer of claim 1 having the formula:
PB-(L 1 -N + (R a )(R b )-L 2 -A(=O)—OR c ) n (X − ) n
wherein
PB is the polymer backbone having n pendant groups L 1 -N + (R a )(R b )-L 2 -A(=O)—OR c );
N + is the cationic center;
R a and R b are independently selected from hydrogen, alkyl, and aryl, or taken together with N + form a cationic center;
A(=O)—OR c is the hydrolyzable group, wherein A is selected from the group consisting of C, S, SO, P, or PO, and R c is an alkyl, aryl, acyl, or silyl group that may be further substituted with one or more substituents;
L 1 is a linker that covalently couples the cationic center to the polymer backbone;
L 2 is a linker that covalently couples the cationic center to the hydrolyzable group;
X − is the counter ion associated with the cationic center; and
n is an integer from about 10 to about 10,000,
wherein at least a portion of the counter ions are antimicrobial agents, antibacterial agents, or antifungal agents, and/or
wherein at least a portion of the hydrolyzable groups release an antimicrobial agent, an antibacterial agent, or an antifungal agent.
3. The polymer of claim 1 , wherein at least a portion of the counter ions are selected from the group consisting of antimicrobial agents, antibacterial agents, and antifungal agents.
4. The polymer of claim 1 , wherein at least a portion of the counter ions are selected from the group consisting of C1-C20 carboxylates and C1-C20 alkylsulfonates.
5. The polymer of claim 1 , wherein at least a portion of the counter ions are selected from the group consisting of nucleic acids, amino acids, proteins, and peptides.
6. The polymer of claim 1 , wherein the cationic center is selected from the group consisting of ammonium, imidazolium, triazaolium, pyridinium, morpholinium, oxazolidinium, pyrazinium, pyridazinium, pyrimidinium, piperazinium, and pyrrolidinium.
7. The polymer of claim 2 , wherein R a and R b are independently selected from the group consisting of C1-C10 straight chain and branched alkyl groups.
8. The polymer of claim 2 , wherein L 1 is selected from the group consisting of —C(═O)O—(CH 2 ) n — and —C(═O)NH—(CH 2 ) n —, wherein n is an integer from 1 to 20.
9. The polymer of claim 2 , wherein L 2 is —(CH 2 ) n —, where n is an integer from 1 to 20.
10. The polymer of claim 2 , wherein A is selected from the group consisting of C, SO, and PO.
11. The polymer of claim 2 , wherein R 1 is C1-C20 alkyl.
12. The polymer of claim 2 , wherein X − is selected from the group consisting of halide, carboxylate, alkylsulfonate, sulfate; nitrate, perchlorate, tetrafluoroborate, hexafluorophosphate, trifluoromethylsulfonate, bis(trifluoromethylsulfonyl)amide, lactate, and salicylate.
13. The polymer of claim 1 , wherein the polymer is crosslinked.
14. The polymer of claim 1 , wherein the polymer is a hydrogel.
15. A polymer having a plurality of repeating units, the repeating units having the formula:
—[CH 2 —C(R d )] n -L 1 -N + (R a )(R b )-L 2 -A(=O)—OR c X −
wherein
—[CH 2 —C(R d )] n — defines a polymer backbone having n repeating units;
R d is selected from the group consisting of hydrogen, fluorine, trifluoromethyl, and C1-C6 alkyl;
n is 10 to 10,000;
N + is a cationic center;
R a and R b are independently selected from hydrogen, alkyl, and aryl, or taken together with N + form a cationic center;
A(=O)—OR c is a hydrolyzable group, wherein A is selected from the group consisting of C, S, SO, P, or PO, and R c is an alkyl, aryl, acyl, or silyl group that may be further substituted with one or more substituents;
L 1 is a linker that covalently couples the cationic center to the polymer backbone;
L 2 is a linker that covalently couples the cationic center to the hydrolyzable group; and
X − is the counter ion associated with the cationic center,
wherein at least a portion of the counter ions are antimicrobial agents, antibacterial agents, or antifungal agents, and/or
wherein at least a portion of the hydrolyzable groups release an antimicrobial agent, an antibacterial agent, or an antifungal agent.
16. The polymer of claim 15 , wherein the polymer is a homopolymer.
17. The polymer of claim 15 , wherein the polymer is a copolymer.
18. The polymer of claim 17 , wherein the copolymer is a random copolymer.
19. The polymer of claim 17 , wherein the copolymer is a block copolymer.
20. The polymer of claim 15 , wherein the copolymer comprises a repeating unit selected from the group consisting of a hydrophobic repeating unit, an anionic repeating unit, and a zwitterionic repeating unit.
21. The polymer of claim 15 , wherein the polymer is crosslinked.
22. The polymer of claim 15 , wherein the polymer is a hydrogel.
23. A surface of a substrate, wherein the surface comprises a polymer of claim 1 .
24. The surface of claim 23 , wherein the substrate is selected from the group consisting of a particle, a drug carrier, non-viral gene delivery system, a biosensor, a membrane, an implantable sensor, a subcutaneous sensor, an implant, and a contact lens.
25. The surface of claim 23 , wherein the substrate is an implantable medical device selected from the group consisting of an ear drainage tube, feeding tube, glaucoma drainage tube, hydrocephalous shunt, keratoprosthesis, nerve guidance tube, urinary catheter, tissue adhesive, x-ray guide, an artificial joint, artificial heart valve, artificial blood vessel, pacemaker, left ventricular assist device (LVAD), artery graft, tissue scaffold, and stent.